BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2914905)

  • 1. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro.
    Chodosh LA; Fire A; Samuels M; Sharp PA
    J Biol Chem; 1989 Feb; 264(4):2250-7. PubMed ID: 2914905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of dichloro-beta-D-ribofuranosylbenzimidazole: effect on in vitro transcription.
    Zandomeni R; Mittleman B; Bunick D; Ackerman S; Weinmann R
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3167-70. PubMed ID: 6954467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.
    Zandomeni R; Zandomeni MC; Shugar D; Weinmann R
    J Biol Chem; 1986 Mar; 261(7):3414-9. PubMed ID: 3456346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DRB (5,6 dichloro-beta-D-ribofuranosylbenzimidazole)-resistant adenovirus mRNA.
    Vennström B; Persson H; Pettersson U; Philipson L
    Nucleic Acids Res; 1979 Nov; 7(6):1405-18. PubMed ID: 503856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB.
    Clement JQ; Wilkinson MF
    J Mol Biol; 2000 Jun; 299(5):1179-91. PubMed ID: 10873444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of DRB. III. Effect on specific in vitro initiation of transcription.
    Zandomeni R; Bunick D; Ackerman S; Mittleman B; Weinmann R
    J Mol Biol; 1983 Jul; 167(3):561-74. PubMed ID: 6876157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription of the beta-hemoglobin gene in vivo at initiation.
    Mukherjee R; Molloy GR
    J Biol Chem; 1987 Oct; 262(28):13697-705. PubMed ID: 3477544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole.
    Tamm I; Kikuchi T
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5750-4. PubMed ID: 293679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. II. A resistant human cell mutant with an altered transcriptional machinery.
    Mittleman B; Zandomeni R; Weinmann R
    J Mol Biol; 1983 Apr; 165(3):461-73. PubMed ID: 6188848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mammalian RNA polymerase by 5,6-dichlororibofuranosylbenzimidazole (DRB) and DRB triphosphate.
    Dreyer C; Hausen P
    Nucleic Acids Res; 1978 Sep; 5(9):3325-35. PubMed ID: 704359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of premature termination of transcription of the mouse beta-globin gene by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tweeten KA; Molloy GR
    Nucleic Acids Res; 1981 Jul; 9(14):3307-19. PubMed ID: 6269079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I; Kikuchi T
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):238-43. PubMed ID: 6191332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis.
    Meulia T; Krumm A; Groudine M
    Mol Cell Biol; 1993 Sep; 13(9):5647-58. PubMed ID: 8355707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on a protein kinase.
    Zandomeni R; Weinmann R
    J Biol Chem; 1984 Dec; 259(23):14804-11. PubMed ID: 6501318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.
    Sehgal PB; Derman E; Molloy GR; Tamm I; Darnell JE
    Science; 1976 Oct; 194(4263):431-3. PubMed ID: 982026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of hnRNA synthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Requirement of a free 3'-hydroxyl group, but not 2'- or 5'-hydroxyls.
    Egyházi E; Ossoinak A; Tayip U; Kazimierczuk Z; Shugar D
    Biochim Biophys Acta; 1982 May; 697(2):213-20. PubMed ID: 7104357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site of premature termination of late transcription of simian virus 40 DNA: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
    Skolnik-David H; Hay N; Aloni Y
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2743-7. PubMed ID: 6283541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear transcription in vitro. Sensitivity to inhibition by ribosyldichlorobenzimidazole and rifamycin AF/013.
    Winicov I
    Biochemistry; 1979 Apr; 18(8):1575-82. PubMed ID: 427132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II.
    Zandomeni RO
    Biochem J; 1989 Sep; 262(2):469-73. PubMed ID: 2803263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase.
    Yankulov K; Yamashita K; Roy R; Egly JM; Bentley DL
    J Biol Chem; 1995 Oct; 270(41):23922-5. PubMed ID: 7592583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.